Literature DB >> 28214961

Obesity and kidney disease: hidden consequences of the epidemic.

Csaba P Kovesdy1,2, Susan L Furth3, Carmine Zoccali4.   

Abstract

Obesity has become a worldwide epidemic, and its prevalence has been projected to grow by 40% in the next decade. This increasing prevalence has implications for the risk of diabetes, cardiovascular disease and also for Chronic Kidney Disease. A high body mass index is one of the strongest risk factors for new-onset Chronic Kidney Disease. In individuals affected by obesity, a compensatory hyperfiltration occurs to meet the heightened metabolic demands of the increased body weight. The increase in intraglomerular pressure can damage the kidneys and raise the risk of developing Chronic Kidney Disease in the long-term. The incidence of obesity-related glomerulopathy has increased ten-fold in recent years. Obesity has also been shown to be a risk factor for nephrolithiasis, and for a number of malignancies including kidney cancer. This year the World Kidney Day promotes education on the harmful consequences of obesity and its association with kidney disease, advocating healthy lifestyle and health policy measures that makes preventive behaviors an affordable option.

Entities:  

Keywords:  Chronic kidney disease; Kidney cancer; Nephrolithiasis; Obesity; Prevention

Mesh:

Year:  2017        PMID: 28214961     DOI: 10.1007/s40620-017-0377-y

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  87 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study.

Authors:  Meredith C Foster; Shih-Jen Hwang; Joseph M Massaro; Udo Hoffmann; Ian H DeBoer; Sander J Robins; Ramachandran S Vasan; Caroline S Fox
Journal:  Obesity (Silver Spring)       Date:  2010-12-23       Impact factor: 5.002

3.  Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Noriko Kuwae; Dennis Y Wu; Ronney S Shantouf; Denis Fouque; Stefan D Anker; Gladys Block; Joel D Kopple
Journal:  Am J Clin Nutr       Date:  2006-02       Impact factor: 7.045

4.  Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.

Authors:  Rena R Wing; Paula Bolin; Frederick L Brancati; George A Bray; Jeanne M Clark; Mace Coday; Richard S Crow; Jeffrey M Curtis; Caitlin M Egan; Mark A Espeland; Mary Evans; John P Foreyt; Siran Ghazarian; Edward W Gregg; Barbara Harrison; Helen P Hazuda; James O Hill; Edward S Horton; Van S Hubbard; John M Jakicic; Robert W Jeffery; Karen C Johnson; Steven E Kahn; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Maria G Montez; Anne Murillo; David M Nathan; Jennifer Patricio; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; David Reboussin; Judith G Regensteiner; Amy D Rickman; Donna H Ryan; Monika Safford; Thomas A Wadden; Lynne E Wagenknecht; Delia S West; David F Williamson; Susan Z Yanovski
Journal:  N Engl J Med       Date:  2013-06-24       Impact factor: 91.245

5.  Prevalence of kidney stones in the United States.

Authors:  Charles D Scales; Alexandria C Smith; Janet M Hanley; Christopher S Saigal
Journal:  Eur Urol       Date:  2012-03-31       Impact factor: 20.096

Review 6.  The endotoxin-lipoprotein hypothesis.

Authors:  M Rauchhaus; A J Coats; S D Anker
Journal:  Lancet       Date:  2000-09-09       Impact factor: 79.321

7.  Body mass index and the risk of development of end-stage renal disease in a screened cohort.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Kozen Kinjo; Taku Inoue; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

Review 8.  The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases.

Authors:  Christiane Rüster; Gunter Wolf
Journal:  Semin Nephrol       Date:  2013-01       Impact factor: 5.299

9.  Body mass index in 1.2 million adolescents and risk for end-stage renal disease.

Authors:  Asaf Vivante; Eliezer Golan; Dorit Tzur; Adi Leiba; Amir Tirosh; Karl Skorecki; Ronit Calderon-Margalit
Journal:  Arch Intern Med       Date:  2012-11-26

10.  Association of age and BMI with kidney function and mortality: a cohort study.

Authors:  Jun Ling Lu; Miklos Z Molnar; Adnan Naseer; Margit K Mikkelsen; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Lancet Diabetes Endocrinol       Date:  2015-07-30       Impact factor: 32.069

View more
  12 in total

1.  Prediabetes is associated with glomerular hyperfiltration in a European Mediterranean cohort study.

Authors:  Antonio Rodriguez-Poncelas; Gabriel Coll-de-Tuero; Jordi Blanch; Marc Comas-Cufí; Marc Saez; Maria Antònia Barceló
Journal:  J Nephrol       Date:  2018-08-27       Impact factor: 3.902

2.  Para-perirenal distribution of body fat is associated with reduced glomerular filtration rate regardless of other indices of adiposity in hypertensive patients.

Authors:  Giulio Geraci; Marta Maria Zammuto; Alessandro Mattina; Luca Zanoli; Calogero Geraci; Antonio Granata; Emilio Nardi; Pasquale Mario Fatuzzo; Santina Cottone; Giuseppe Mulè
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-09-14       Impact factor: 3.738

3.  Overlapping obesity-related glomerulopathy and immunoglobulin A nephropathy: clinical and pathologic characteristics and prognosis.

Authors:  Junjun Zhang; Yongli Wang; Zhangsuo Liu; Bo Huang; Xutong Wang; Minhua Xie; Dan Yu; Ruxue Guo; Panfei Wang
Journal:  Clin Exp Nephrol       Date:  2021-04-02       Impact factor: 2.801

4.  Impact of age and renal function on urine chemistry in patients with calcium oxalate kidney stones.

Authors:  Triet Vincent M Tran; Xilong Li; Beverley Adams-Huet; Naim M Maalouf
Journal:  Urolithiasis       Date:  2021-02-13       Impact factor: 3.436

5.  Beneficial Effects of Isoflavones in the Kidney of Obese Rats Are Mediated by PPAR-Gamma Expression.

Authors:  Edson de Andrade Pessoa; Márcia Bastos Convento; Bianca Castino; Ala Moana Leme; Andréia Silva de Oliveira; Alef Aragão; Sheila Marques Fernandes; Adriana Carbonel; Cassiane Dezoti; Maria de Fátima Vattimo; Nestor Schor; Fernanda Teixeira Borges
Journal:  Nutrients       Date:  2020-06-01       Impact factor: 5.717

6.  Frequency of television viewing and association with overweight and obesity among women of the reproductive age group in Myanmar: results from a nationwide cross-sectional survey.

Authors:  Rajat Das Gupta; Ibrahim Hossain Sajal; Mehedi Hasan; Ipsita Sutradhar; Mohammad Rifat Haider; Malabika Sarker
Journal:  BMJ Open       Date:  2019-03-20       Impact factor: 2.692

7.  Omentin protects H9c2 cells against docetaxel cardiotoxicity.

Authors:  Ricardo Lage; María Cebro-Márquez; Moisés Rodríguez-Mañero; José Ramón González-Juanatey; Isabel Moscoso
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

8.  Increased Risk of NAFLD in Adults with Glomerular Hyperfiltration: An 8-Year Cohort Study Based on 147,162 Koreans.

Authors:  Dae-Jeong Koo; Mi Yeon Lee; Inha Jung; Sun Joon Moon; Hyemi Kwon; Eun-Jung Rhee; Cheol-Young Park; Won-Young Lee; Ki Won Oh; Se Eun Park
Journal:  J Pers Med       Date:  2022-07-14

9.  Sleeve Gastrectomy-Induced Body Mass Index Reduction Increases the Intensity of Taste Perception's and Reduces Bitter-Induced Pleasantness in Severe Obesity.

Authors:  Sara Rurgo; Elena Cantone; Marcella Pesce; Eleonora Efficie; Mario Musella; Barbara Polese; Barbara De Conno; Marta Pagliaro; Luisa Seguella; Bruna Guida; Giuseppe Esposito; Giovanni Sarnelli
Journal:  J Clin Med       Date:  2022-07-07       Impact factor: 4.964

Review 10.  Weight Loss in Advanced Chronic Kidney Disease: Should We Consider Individualised, Qualitative, ad Libitum Diets? A Narrative Review and Case Study.

Authors:  Irene Capizzi; Luigi Teta; Federica Neve Vigotti; Giuliana Tognarelli; Valentina Consiglio; Stefania Scognamiglio; Giorgina Barbara Piccoli
Journal:  Nutrients       Date:  2017-10-11       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.